Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 20% ± 3% | |
dendritic cell | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of L3MBTL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1786.44 | 459 / 459 | 100% | 18.95 | 1118 / 1118 |
liver | 100% | 1387.01 | 226 / 226 | 100% | 12.10 | 406 / 406 |
prostate | 100% | 2607.86 | 245 / 245 | 100% | 20.12 | 502 / 502 |
skin | 100% | 1805.21 | 1809 / 1809 | 100% | 24.11 | 472 / 472 |
stomach | 100% | 1606.61 | 359 / 359 | 100% | 14.70 | 286 / 286 |
uterus | 100% | 2291.78 | 170 / 170 | 100% | 18.64 | 459 / 459 |
brain | 100% | 2233.93 | 2641 / 2642 | 100% | 19.97 | 705 / 705 |
esophagus | 100% | 1938.54 | 1444 / 1445 | 100% | 14.88 | 183 / 183 |
thymus | 100% | 2145.75 | 653 / 653 | 100% | 16.46 | 604 / 605 |
lung | 100% | 1714.71 | 577 / 578 | 100% | 15.55 | 1155 / 1155 |
intestine | 100% | 1972.86 | 966 / 966 | 100% | 14.68 | 526 / 527 |
pancreas | 100% | 1000.56 | 327 / 328 | 100% | 15.20 | 178 / 178 |
bladder | 100% | 2251.76 | 21 / 21 | 100% | 15.53 | 502 / 504 |
kidney | 100% | 1741.82 | 89 / 89 | 100% | 15.24 | 897 / 901 |
ovary | 100% | 2078.18 | 180 / 180 | 100% | 11.35 | 428 / 430 |
adrenal gland | 100% | 2167.51 | 258 / 258 | 98% | 12.80 | 226 / 230 |
adipose | 100% | 1559.01 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 21.43 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 32.35 | 29 / 29 |
spleen | 100% | 2649.75 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.91 | 1 / 1 |
blood vessel | 100% | 1600.45 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 1170.09 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1262.43 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 1230.24 | 872 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0035064 | Molecular function | methylated histone binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0042393 | Molecular function | histone binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | L3MBTL2 |
Protein name | L3MBTL histone methyl-lysine binding protein 2 Lethal(3)malignant brain tumor-like protein 2 (H-l(3)mbt-like protein 2) (L(3)mbt-like protein 2) Lethal(3)malignant brain tumor-like protein 2 |
Synonyms | hCG_41118 |
Description | FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes, probably via a modification of chromatin, rendering it heritably changed in its expressibility. Its association with a chromatin-remodeling complex suggests that it may contribute to prevent expression of genes that trigger the cell into mitosis. Binds to monomethylated and dimethylated 'Lys-20' on histone H4. Binds histone H3 peptides that are monomethylated or dimethylated on 'Lys-4', 'Lys-9' or 'Lys-27'. . FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes, probably via a modification of chromatin, rendering it heritably changed in its expressibility. Its association with a chromatin-remodeling complex suggests that it may contribute to prevent expression of genes that trigger the cell into mitosis. Binds to monomethylated and dimethylated 'Lys-20' on histone H4. Binds histone H3 peptides that are monomethylated or dimethylated on 'Lys-4', 'Lys-9' or 'Lys-27'. . FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes, probably via a modification of chromatin, rendering it heritably changed in its expressibility. Its association with a chromatin-remodeling complex suggests that it may contribute to prevent expression of genes that trigger the cell into mitosis. Binds to monomethylated and dimethylated 'Lys-20' on histone H4. Binds histone H3 peptides that are monomethylated or dimethylated on 'Lys-4', 'Lys-9' or 'Lys-27'. . |
Accessions | H0Y5M2 ENST00000452106.5 [Q969R5-2] ENST00000216237.10 [Q969R5-1] Q969R5 H7C228 ENST00000450939.1 A0A0S2Z5Q2 ENST00000449635.5 A0A0S2Z5X6 |